	Clinical application of urinary NTx in patients with bone metastases from lung cancer. J Bone Oncol Jiang L, Zhang P, Wang Z, Chang X, Lu P, Zhang Y, Sang G. PMID: 42519555 [PubMed - as supplied by publisher]
	Single-cell and spatial omics in non-small cell lung cancer: dissecting metabolic reprogramming and tumor-immune ecosystems for precision pharmacology. Front Immunol Lian Z, Wu XJ, Zhou Y, Tang P, Ge H. PMID: 42519324 [PubMed - as supplied by publisher]
	Systematic gravity-induced posterior tumour drift in free-breathing lung stereotactic ablative radiotherapy. Phys Imaging Radiat Oncol Merring-Mikkelsen L, Sand HMB, Brincker MH. PMID: 42519161 [PubMed - as supplied by publisher]
	Real-world diagnostic pathways and treatment patterns for suspected lung cancer in Japan: a nationwide claims database analysis. ESMO Real World Data Digit Oncol Matsumoto Y, Hong YE, Shim H, Shin M, Furuse H, Tsuchida T. PMID: 42518715 [PubMed - as supplied by publisher]
	EV-Mediated Oncogenic Regulation in Lung Cancer and Clinical Translation: From Liquid Biopsy to Targeted Delivery Systems. Int J Nanomedicine Fang J, Li J, Yan L, Yang Y, Chen Y, Zhang X, Zhang C. PMID: 42518680 [PubMed - as supplied by publisher]
	Effect of Exposure to Inhaled Corticosteroids on Lung Cancer Incidence - A Comparison of Earlier Study Methodology on the Financial Database of the Hungarian National Health Insurance Fund. Int J Chron Obstruct Pulmon Dis Santa B, Tomisa G, Nemeth L, Balázs T, Südi A, Engi B, Müller V, Eszes N, Tamási L. PMID: 42518632 [PubMed - as supplied by publisher]
	Combination of polygonatum sibiricum and hedyotis diffusa induces pyroptosis in non-small cell lung cancer cells via the TLR4/NLRP3/Caspase-1/GSDMD pathway: an in vitro and in vivo study using medicated serum and herbal extract. Front Pharmacol Mao L, Jiang L, Zhou Y, Xu S, Lou T, Lu W, Zhu G, Chen J. PMID: 42518350 [PubMed - as supplied by publisher]
	Medicaid Expansion and Place-Based Disparities in Non-Small Cell Lung Cancer Diagnosis and Survival. JAMA Netw Open Okon M, Han X, Zhao J, Yabroff KR, Mayo R, Truong K, Schafer EJ, Jemal A, Zhang L. PMID: 42518237 [PubMed - as supplied by publisher]
	A three-gene signature correlated with MAPK/ERK activation characterizes acquired resistance to EGFR-tyrosine kinase inhibitors in non-small cell lung cancer. Oncol Lett Qin C, Zhang W, Tang D, Yang Y, Liang B, Hu Z, Zhang Y, Ye T, Xu W. PMID: 42516805 [PubMed - as supplied by publisher]
	Lung Cancer Screening in California and Los Angeles County: A Landscape Analysis. Cureus Tupper HI, Gao YA, Cummings AL. PMID: 42516477 [PubMed - as supplied by publisher]
	Disproportionality analysis of drug-related interstitial lung disease in patients with head and neck squamous cell carcinoma: a signal mining study. Front Immunol Ju J, Liu Z, Cao L, Xia L, Zhang P, Wang Y. PMID: 42516366 [PubMed - as supplied by publisher]
	WCRF/AICR dietary adherence-associated metabolic bridge phenotypes and incident lung cancer risk: a prospective cohort study of the UK Biobank. Front Nutr Liang G, Ying J, He J, Yu H, Chen T, Tang M, Lin C, Zhang L, Shen W. PMID: 42516230 [PubMed - as supplied by publisher]
	Correction: Clinical benefit and safety of immunotherapy beyond progression in advanced and locally advanced lung cancer: a real-world cohort study. Front Oncol Frontiers Production Office. PMID: 42516132 [PubMed - as supplied by publisher]
	Establishment and Validation of a Necroptosis-Related Long Noncoding RNA Prognostic Model for Non-Small Cell Lung Cancer. Curr Med Chem Yin Z, Han Y, Song P. PMID: 42515887 [PubMed - as supplied by publisher]
	Fluoroquinolone Exposure and Cancer Risk in Interstitial Lung Disease: A Propensity-Score-Matched Cohort Study Using Cox and Competing-Risk Models. Pharmaceuticals (Basel) Sun YF, Chiu YT, Ko YE, Huang YW, Hsieh LK, Lin CL, Kao CH, Yeh JJ. PMID: 42515748 [PubMed - as supplied by publisher]
	Immune Regulation and the Role of Extracellular Vesicles in Non-Small Cell Lung Cancer: Biological Mechanisms and Therapeutic Perspectives. Pharmaceuticals (Basel) Ferrario N, Fortunato O, Ghidotti P. PMID: 42515706 [PubMed - as supplied by publisher]
	Perioperative Immunonutrition in Patients Undergoing Lung Cancer Surgery: Current Evidence and Future Perspectives. Nutrients Werbli, Skrzypczak PJ, Roszak M, Bryl M, Piwkowski C, Gabryel P. PMID: 42514450 [PubMed - as supplied by publisher]
	Integrating Nutrition and Exercise to Mitigate Cardiometabolic Risk and Enhance Outcomes in Lung Cancer During the Era of Immunotherapy and Targeted Therapy. Nutrients Gallucci G, Inno A, Fugazzaro S, Costi S, Leo SD, Pezzuolo D, Zanelli F, Ciammella P, Navazio A, Pinto C, Tarantini L. PMID: 42514359 [PubMed - as supplied by publisher]
	Diagnostic and Prognostic Roles of Blood-Based Immune Biomarkers in Non-Small Cell Lung Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses. Life (Basel) Zhao P, Ling R, Li R, Kam YW. PMID: 42514200 [PubMed - as supplied by publisher]
	Real-World Insights into Stage I-III Non-Small Cell Lung Cancer in Spain in the Pre-Immunotherapy Era Using AI Techniques: The IntellyLUNG Study. Life (Basel) Corral Jaime J, de Castro J, Azkarate A, García Ledo G, Calles A, Marsé R, Parreira ASFM, Villamayor J, Gutiérrez-Sainz L, Benítez-Fuentes JD, Elía DC, Gutiérrez N, Valles MA, Sarró E, López N, Savana Research Group. PMID: 42514189 [PubMed - as supplied by publisher]

Articles 1 - 20 / 160877

Page 1 of 8044



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy